We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » High Court to Review 180-Day Notification Requirement for Biosimilar
High Court to Review 180-Day Notification Requirement for Biosimilar
The Supreme Court has agreed to hear a case centered on whether a 180-day notification is mandatory or optional — when the appropriate disclosures are made — before a biosimilar launch.